- Patients must have met the inclusion criteria for the preceding fibromyalgia Protocol
A0081100, and must have received pregabalin/placebo under double-blind conditions.
- Patients may not participate in the study if they experienced a serious adverse event
during the previous fibromyalgia Study A0081100 which was determined to be related to
the study medication by the investigator or the sponsor.